Cargando…
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
BACKGROUND: Carnitine palmitoyl transferase 1A (CPT1A), the key regulator of fatty acid oxidation, contributes to tumor metastasis and therapeutic resistance. We aimed to identify its clinical significance as a biomarker for the diagnosis and prediction of breast cancer. METHODS: Western blot, ELISA...
Autores principales: | Tan, Zheqiong, Zou, Yaru, Zhu, Man, Luo, Zhenzhao, Wu, Tangwei, Zheng, Chao, Xie, Aqing, Wang, Hui, Fang, Shiqiang, Liu, Shuiyi, Li, Yong, Lu, Zhongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048260/ https://www.ncbi.nlm.nih.gov/pubmed/33858374 http://dx.doi.org/10.1186/s12885-021-08134-7 |
Ejemplares similares
-
Correction: Carnitine palmitoyl transferase 1 A is a novel diagnostic and predictive biomarker for breast cancer
por: Tan, Zheqiong, et al.
Publicado: (2023) -
Association of the vitamin D metabolism gene GC and CYP27B1 polymorphisms with cancer susceptibility: a meta-analysis and trial sequential analysis
por: Zhu, Man, et al.
Publicado: (2019) -
microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1
por: Wang, Hui, et al.
Publicado: (2019) -
Fenofibrate Therapy in Carnitine Palmitoyl Transferase Type 2 Deficiency
por: Hamilton-Craig, I., et al.
Publicado: (2012) -
Bone scinitigraphy in rhabdomyolysis associated with carnitine palmitoyl transferase deficiency
por: Wong, Jonathan, et al.
Publicado: (2010)